Recent observational studies showed that the ApoB/ApoA1 ratio can predict the progression of non-major coronary artery lesions and the occurrence of MACE in patients with diabetes complicated with acute coronary syndrome after percutaneous coronary intervention [24]. This evidence concerns the gene APOA1 and diabetes mellitus.